Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Faselis

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Current Vascular Pharmacology|March 20, 2020
Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future PerspectivesDimitrios Patoulias, Konstantinos Stavropoulos, Konstantinos Imprialos, et al.
Frontiers in Cardiovascular Medicine|July 25, 2025
Translation of clinical practice to research: the VETS and ETHOS epidemiologic prospective cohortsJonathan Myers, Peter Kokkinos, Immanuel Babu Henry Samuel, et al.
American Journal of Medicine Open|April 20, 2026
Risk of a Dementia Diagnosis in Community-Dwelling Older Adults With Normal MMSE Scores in the United StatesMo-Kyung Sin, Richard M Allman, Yuting Lin, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2014
Exercise capacity and all-cause mortality in male veterans with hypertension aged ≥70 yearsCharles Faselis, Michael Doumas, Andreas Pittaras, et al.
Journal of Healthcare Informatics Research|March 8, 2021
Understanding Demographic Risk Factors for Adverse Outcomes in COVID-19 Patients: Explanation of a Deep Learning ModelYijun Shao, Ali Ahmed, Angelike P Liappis, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 3, 2009
Protective effects of angiotensin-converting enzyme inhibitors in high-risk African American men with coronary heart diseaseVasilios Papademetriou, Christodoulos Kaoutzanis, Michael Dumas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 26, 2013
Masked hypertension and atherogenesis: the impact of apelin and relaxin plasma levelsDimitris P Papadopoulos, Iordanis Mourouzis, Charles Faselis, et al.
Thrombosis Research|January 29, 2013
The infrequent removal of retrievable IVC filtersJoelle El-Amm, Dalia A Mobarek, Lena Furmark, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 9, 2014
Apelin and relaxin plasma levels in young healthy offspring of patients with essential hypertensionDimitris P Papadopoulos, Thomas Makris, Despina Perrea, et al.
Current Pharmaceutical Design|March 9, 2019
Mineralocorticoid Receptor Antagonists in Essential and Resistant HypertensionKonstantinos P Imprialos, Sofia Bouloukou, Georgios Kerpiniotis, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Current Vascular Pharmacology|March 20, 2020
Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future PerspectivesDimitrios Patoulias, Konstantinos Stavropoulos, Konstantinos Imprialos, et al.
Frontiers in Cardiovascular Medicine|July 25, 2025
Translation of clinical practice to research: the VETS and ETHOS epidemiologic prospective cohortsJonathan Myers, Peter Kokkinos, Immanuel Babu Henry Samuel, et al.
American Journal of Medicine Open|April 20, 2026
Risk of a Dementia Diagnosis in Community-Dwelling Older Adults With Normal MMSE Scores in the United StatesMo-Kyung Sin, Richard M Allman, Yuting Lin, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2014
Exercise capacity and all-cause mortality in male veterans with hypertension aged ≥70 yearsCharles Faselis, Michael Doumas, Andreas Pittaras, et al.
Journal of Healthcare Informatics Research|March 8, 2021
Understanding Demographic Risk Factors for Adverse Outcomes in COVID-19 Patients: Explanation of a Deep Learning ModelYijun Shao, Ali Ahmed, Angelike P Liappis, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 3, 2009
Protective effects of angiotensin-converting enzyme inhibitors in high-risk African American men with coronary heart diseaseVasilios Papademetriou, Christodoulos Kaoutzanis, Michael Dumas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 26, 2013
Masked hypertension and atherogenesis: the impact of apelin and relaxin plasma levelsDimitris P Papadopoulos, Iordanis Mourouzis, Charles Faselis, et al.
Thrombosis Research|January 29, 2013
The infrequent removal of retrievable IVC filtersJoelle El-Amm, Dalia A Mobarek, Lena Furmark, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 9, 2014
Apelin and relaxin plasma levels in young healthy offspring of patients with essential hypertensionDimitris P Papadopoulos, Thomas Makris, Despina Perrea, et al.
Current Pharmaceutical Design|March 9, 2019
Mineralocorticoid Receptor Antagonists in Essential and Resistant HypertensionKonstantinos P Imprialos, Sofia Bouloukou, Georgios Kerpiniotis, et al.
Pageof 14